XENETIC BIOSCIENCES, INC. Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate
XENETIC BIOSCIENCES, INC. (XBIO) had Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate of 6.00% as of 2016-08-31, per its 10-Q filed 2013-07-17.
Discontinued › Notes › Debt
us-gaap:LongTermDebtPercentageBearingFixedInterestRate · last filed 2013-07-17
- 2016-08-31: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 6.00%.
- 2011-08-11: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 6.00%.
| Period end | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate |
|---|---|
| 2016-08-31 | 6.00% 10-Q · filed 2013-07-17 |
| 2011-08-11 | 6.00% 10-Q · filed 2013-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |